Search Results - Herce-Hagiwara, B.

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    HPR18 What Is the Impact of Including Outcomes-Based Agreements on the Cost-Effectiveness of Cell and Gene Therapies? A Case Example of Zynteglo for Transfusion-Dependent Beta Thalassemia

    HPR18 What Is the Impact of Including Outcomes-Based Agreements on the Cost-Effectiveness of Cell and Gene Therapies? A Case Example of Zynteglo for Transfusion-Dependent Beta Thal... by Richardson, M, Beaudoin, F, Rind, D.M., Synnott, P, Herce-Hagiwara, B, Ollendorf, D

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    EE470 The Impact of a Cost Savings Cap on the Cost Effectiveness of Valoctocogene Roxaparvovec for the Treatment of Hemophilia A in the United States

    EE470 The Impact of a Cost Savings Cap on the Cost Effectiveness of Valoctocogene Roxaparvovec for the Treatment of Hemophilia A in the United States by Sarker, J, Tice, JA, Herce-Hagiwara, B., Fahim, S.M., Chu, J, Agboola, F, Pearson, S, Rind, D.M., Walton, S.M.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    EE555 Cost-Effectiveness of Etranacogene Dezaparvovec for the Treatment of Hemophilia B

    EE555 Cost-Effectiveness of Etranacogene Dezaparvovec for the Treatment of Hemophilia B by Sarker, J., Moradi, A., Whittington, M., Tice, J.A., Herce-Hagiwara, B., Fahim, S.M., Chu, J., Agboola, F.O., Pearson, S., Rind, D.M., Walton, S.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: